YMDAF yields 3.70% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, YMDAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YMDAF + PFE for your $10,000?
Yamada Holdings Co., Ltd., together with its subsidiaries, operates in the consumer electronics retailing activities. Its Consumer Electronics segment operates a network of consumer electronics stores that sell home appliances, home interiors, and living and furniture products, as well as engages in the specialty retailing of private label apparel products. The company's Housing segment provides smart and custom-built homes, as well as engages in home building, rebuilding, and sale, and renovation activities. Its Finance segment develops a range of financial products in the new builds, renovations, payment services, insurance products, and life planning. The company's Environmental segment is involved in the product reuse and recycling, waste reduction and disposal, and recycled materials usage activities. Its Other segment engages in the trading businesses in travel industry, and delivery and installation of electrical appliances. The company was formerly known as Yamada Denki Co., Ltd. and changed its name to Yamada Holdings Co., Ltd. in October 2020. Yamada Holdings Co., Ltd. was founded in 1973 and is headquartered in Takasaki, Japan.
Full YMDAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.